![Hugh Griffith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hugh Griffith
Oprichter bij
NUCANA PLC
Vermogen: 327 600 $ op 31-03-2024
Profiel
Hugh Stephen Griffith is the founder of NuCana Plc, founded in 1997, holding the titles of Chief Executive Officer & Executive Director.
Founder of EdixoMed Ltd., founded in 2011, serving as Non-Executive Director from 2011 to 2023.
Founder of MedAnnex Ltd., founded in 2009, serving as Non-Executive Director from 2010 to 2024.
Founder of Thirty Holdings Ltd., founded in 2018, serving as Non-Executive Director from 2018 to 2023.
Founder of Alida Capital International Ltd., founded in 2009, holding the titles of Chief Executive Officer & Director.
Former jobs include Executive Commercial Director at Ernco 200 LTD in 2002, Manager-Business Development at Abbott Laboratories from 1995 to 2001, Principal at Parke-Davis & Co. Ltd., Principal at Warner Lambert (UK) Ltd. from 1992 to 1995, and Chief Operating Officer at Bioenvision, Inc. from 2004 to 2007.
Education includes undergraduate studies at The University of Stirling and an MBA from Cardiff Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NUCANA PLC 3,96% | 18-03-2026 | 1.260.000 ( 3,96% ) | 327 600 $ | 31-03-2024 |
Actieve functies van Hugh Griffith
| Bedrijven | Functie | Begin |
|---|---|---|
| NUCANA PLC | Oprichter | 28-01-1997 |
Eerdere bekende functies van Hugh Griffith
| Bedrijven | Functie | Einde |
|---|---|---|
MedAnnex Ltd.
 MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology approaches for treating autoimmune diseases | Oprichter | 01-01-2024 |
EdixoMed Ltd.
 EdixoMed Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology | Oprichter | 25-09-2023 |
Thirty Holdings Ltd.
 Thirty Holdings Ltd. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiary develops anti-infective nitric oxide technology platform for healthcare sector | Oprichter | 01-01-2023 |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Operationeel Directeur | 01-12-2007 |
Ernco 200 LTD
 Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy | Corporate Officer/Principal | 01-09-2002 |
Opleiding van Hugh Griffith
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
73
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Health Services |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Ernco 200 LTD
Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy | Health Technology |
Warner Lambert (UK) Ltd.
 Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufacturer and wholesaler of pharmaceuticals and over the counter medicines | Health Technology |
The University of Stirling
 The University of Stirling Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Alida Capital International Ltd.
 Alida Capital International Ltd. Investment ManagersFinance Provides capital and practical assistance for emerging biopharmaceutical companies | Finance |
Cardiff Business School
 Cardiff Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology | Health Technology |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology approaches for treating autoimmune diseases | Commercial Services |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiary develops anti-infective nitric oxide technology platform for healthcare sector | Technology Services |
